171,680 Shares in The Clorox Company $CLX Acquired by Employees Provident Fund Board

Employees Provident Fund Board bought a new stake in The Clorox Company (NYSE:CLX) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 171,680 shares of the company’s stock, valued at approximately $17,310,000.

Several other large investors have also modified their holdings of the business. State Street Corp increased its position in shares of Clorox by 3.5% during the third quarter. State Street Corp now owns 8,434,277 shares of the company’s stock valued at $1,039,946,000 after acquiring an additional 282,794 shares during the last quarter. Invesco Ltd. lifted its stake in Clorox by 22.1% during the 4th quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock worth $492,085,000 after acquiring an additional 884,751 shares in the last quarter. Geode Capital Management LLC lifted its stake in Clorox by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 3,172,233 shares of the company’s stock worth $318,613,000 after acquiring an additional 10,060 shares in the last quarter. Van ECK Associates Corp boosted its holdings in Clorox by 15.7% during the 4th quarter. Van ECK Associates Corp now owns 3,136,405 shares of the company’s stock valued at $316,244,000 after acquiring an additional 426,433 shares during the period. Finally, Two Sigma Investments LP grew its position in Clorox by 33.8% in the 3rd quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock valued at $214,564,000 after acquiring an additional 439,797 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Analyst Ratings Changes

CLX has been the topic of a number of recent research reports. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $91.00 price target on shares of Clorox in a research note on Friday, May 1st. Wells Fargo & Company dropped their price objective on shares of Clorox from $100.00 to $95.00 and set an “equal weight” rating for the company in a report on Monday, May 18th. Citigroup cut their target price on shares of Clorox from $110.00 to $97.00 and set a “neutral” rating on the stock in a research note on Friday, May 1st. Weiss Ratings raised shares of Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, April 13th. Finally, Morgan Stanley dropped their price target on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a research note on Friday, May 1st. One investment analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have issued a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Reduce” and an average price target of $103.40.

Insider Transactions at Clorox

In other Clorox news, Director Pierre R. Breber acquired 5,000 shares of the stock in a transaction dated Tuesday, May 5th. The stock was acquired at an average cost of $85.82 per share, with a total value of $429,100.00. Following the transaction, the director owned 18,000 shares in the company, valued at $1,544,760. The trade was a 38.46% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.63% of the stock is owned by company insiders.

Clorox Stock Up 0.1%

Shares of Clorox stock opened at $95.90 on Friday. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The Clorox Company has a 52-week low of $84.70 and a 52-week high of $132.03. The company has a market capitalization of $11.60 billion, a P/E ratio of 15.57, a P/E/G ratio of 0.50 and a beta of 0.56. The company has a 50 day moving average of $95.71 and a 200 day moving average of $104.82.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. The business had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company’s revenue was up .1% on a year-over-year basis. During the same period last year, the business earned $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, research analysts forecast that The Clorox Company will post 5.61 EPS for the current fiscal year.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.